Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant

Journal of Cardiothoracic Surgery

Volumn 2, Issue 1, 2007, Pages

  Gandhi, Manish J ^a,b   Pierce, Richard A ^a   Zhang, Lini ^a   Moon, Marc R ^a   Despotis, George J ^a   Moazami, Nader ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; HEMATOLOGIC AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLEEDING; FEMALE; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; FACTOR VIIA; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMATOLOGIC AGENTS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 34547811456     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-2-32     Document Type: Article

References (71)

1. McCarthy PM Sabik JF Implantable circulatory support devices as a bridge to heart transplantation Semin Thorac Cardiovasc Surg 1994 6 3 174-180 7948295
2. Dembitsky WP Tector AJ Park S Moskowitz AJ Gelijns AC Ronan NS Piccione W Jr. Holman WL Furukawa S Weinberg AD Heatley G Poirier VL Damme L Long JW Left ventricular assist device performance with long-term circulatory support: Lessons from the REMATCH trial Ann Thorac Surg 2004 78 6 2123-9; discussion 2129-30 10.1016/j.athoracsur.2004.02.030 15561049
3. Herbertson M Recombinant activated factor VII in cardiac surgery Blood Coagul Fibrinolysis 2004 15 Suppl 1 S31-2 10.1097/ 00001721-200405001-00007 15166932
4. Diprose P Herbertson MJ O'Shaughnessy D Gill RS Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebo-controlled pilot study Br J Anaesth 2005 95 5 596-602 10.1093/ bja/aei244 16183679
5. Engoren MC Habib RH Zacharias A Schwann TA Riordan CJ Durham SJ Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg 2002 74 4 1180-1186 10.1016/S0003-4975(02)03766-9 12400765
6. Moulton MJ Creswell LL Mackey ME Cox JL Rosenbloom M Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations J Thorac Cardiovasc Surg 1996 111 5 1037-1046 10.1016/ S0022-5223(96)70380-X 8622301
7. Dacey LJ Munoz JJ Baribeau YR Johnson ER Lahey SJ Leavitt BJ Quinn RD Nugent WC Birkmeyer JD O'Connor GT Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors. Northern New England Cardiovascular Disease Study Group Arch Surg 1998 133 4 442-447 10.1001/archsurg.133.4.442 9565127
8. Unsworth-White MJ Herriot A Valencia O Poloniecki J Smith EE Murday AJ Parker DJ Treasure T Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality Ann Thorac Surg 1995 59 3 664-667 10.1016/0003-4975(94)00995-3 7887708
9. Karkouti K Wijeysundera DN Yau TM Beattie WS Abdelnaem E McCluskey SA Ghannam M Yeo E Djaiani G Karski J The independent association of massive blood loss with mortality in cardiac surgery Transfusion 2004 44 10 1453-1462 10.1111/j.1537-2995.2004.04144.x 15383018
10. Frumento RJ O'Malley CM Bennett-Guerrero E Stroke after cardiac surgery: a retrospective analysis of the effect of aprotinin dosing regimens Ann Thorac Surg 2003 75 2 479-83; discussion 483-4 10.1016/ S0003-4975(02)04475-2 12607657
11. Levy JH Pharmacologic preservation of the hemostatic system during cardiac surgery Ann Thorac Surg 2001 72 5 S1814-20 10.1016/ S0003-4975(01)03218-0 11722115
12. Grounds M Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: A review Blood Rev 2003 17 Suppl 1 S11-21 10.1016/S0268-960X(03)90002-6 14697209
13. Wittenstein B Ng C Ravn H Goldman A Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery Pediatr Crit Care Med 2005 6 4 473-476 10.1097/ 01.PCC.0000162449.55887.B9 15982438
14. Tobias JD Simsic JM Weinstein S Schechter W Kartha V Michler R Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients J Intensive Care Med 2004 19 5 270-273 10.1177/0885066604267783 15358945
15. DiDomenico RJ Massad MG Kpodonu J Navarro RA Geha AS Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass Chest 2005 127 5 1828-1835 10.1378/ chest.127.5.1828 15888865
16. Despotis GJ Joist JH Hogue CW Jr. Alsoufiev A Kater K Goodnough LT Santoro SA Spitznagel E Rosenblum M Lappas DG The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 1995 110 1 46-54 10.1016/S0022-5223(05)80008-X 7609568
17. Despotis GJ Santoro SA Spitznagel E Kater KM Cox JL Barnes P Lappas DG Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 1994 107 1 271-279 8283896
18. Goodnough LT Lublin DM Zhang L Despotis G Eby C Transfusion medicine service policies for recombinant factor VIIa administration Transfusion 2004 44 9 1325-1331 10.1111/j.1537-2995.2004.04052.x 15318856
19. Monroe DM Hoffman M Oliver JA Roberts HR Platelet activity of high-dose factor VIIa is independent of tissue factor Br J Haematol 1997 99 3 542-547 10.1046/j.1365-2141.1997.4463256.x 9401063
20. Monroe DM Roberts HR Mechanism of action of high-dose factor VIIa: points of agreement and disagreement Arterioscler Thromb Vasc Biol 2003 23 1 8-9; discussion 10 10.1161/01.ATV.0000047645.37970.AB 12524217
21. Uhlmann EJ Eby CS Recombinant activated factor VII for non-hemophiliac bleeding patients Curr Opin Hematol 2004 11 3 198-204 10.1097/ 01.moh.0000135405.29702.3c 15257021
22. Hedner U Erhardtsen E Potential role for rFVIIa in transfusion medicine Transfusion 2002 42 1 114-124 10.1046/j.1537-2995.2002.00017.x 11896322
23. Wolberg AS Allen GA Monroe DM Hedner U Roberts HR Hoffman M High dose factor VIIa improves clot structure and stability in a model of haemophilia B Br J Haematol 2005 131 5 645-655 10.1111/ j.1365-2141.2005.05820.x 16351642
24. Despotis G Avidan M Lublin DM Off-label use of recombinant factor VIIA concentrates after cardiac surgery Ann Thorac Surg 2005 80 1 3-5 10.1016/ j.athoracsur.2005.04.007 15975330
25. Roberts HR Recombinant factor VIIa (Novoseven) and the safety of treatment Semin Hematol 2001 38 4 Suppl 12 48-50 10.1016/ S0037-1963(01)90148-9 11735111
26. Roberts HR Recombinant factor VIIa: A general hemostatic agent? Yes J Thromb Haemost 2004 2 10 1691-1694 10.1111/j.1538-7836.2004.00909.x 15456475
27. Levi M Peters M Buller HR Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review Crit Care Med 2005 33 4 883-890 10.1097/01.CCM.0000159087.85970.38 15818119
28. Dietrich W Spannagl M Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery Anesth Analg 2002 94 5 1369-70; author reply 1370-1 10.1097/00000539-200205000-00070 11973226
29. Bui JD Despotis GD Trulock EP Patterson GA Goodnough LT Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII J Thorac Cardiovasc Surg 2002 124 4 852-854 10.1067/mtc.2002.126038 12324751
30. Lodge JP Jonas S Oussoultzoglou E Malago M Jayr C Cherqui D Anthuber M Mirza DF Kuhlman L Bechstein WO Diaz JC Tartiere J Eyraud D Fridberg M Erhardtsen E Mimoz O Recombinant coagulation factor VIIa in major liver resection: A randomized, placebo-controlled, double-blind clinical trial Anesthesiology 2005 102 2 269-275 10.1097/00000542-200502000-00006 15681939
31. Raobaikady R Redman J Ball JA Maloney G Grounds RM Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: A double-blind, randomized, placebo-controlled trial Br J Anaesth 2005 94 5 586-591 10.1093/bja/aei102 15734783
32. Boffard KD Riou B Warren B Choong PI Rizoli S Rossaint R Axelsen M Kluger Y Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials J Trauma 2005 59 1 8-15; discussion 15-8 16096533
33. Friederich PW Geerdink MG Spataro M Messelink EJ Henny CP Buller HR Levi M The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: The PROSE study Blood Coagul Fibrinolysis 2000 11 Suppl 1 S129-32 10850578
34. O'Connell KA Wood JJ Wise RP Lozier JN Braun MM Thromboembolic adverse events after use of recombinant human coagulation factor VIIa Jama 2006 295 3 293-298 10.1001/jama.295.3.293 16418464
35. Mayer SA Brun NC Begtrup K Broderick J Davis S Diringer MN Skolnick BE Steiner T Recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 2005 352 8 777-785 10.1056/NEJMoa042991 15728810
36. von Heymann C Hotz H Konertz W Kox WJ Spies C Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 2002 16 5 615-616 10.1053/jcan.2002.126927 12407617
37. Tobias JD Berkenbosch JW Muruve NA Schmaltz RA Correction of a coagulopathy using recombinant factor VII before removal of an intra-aortic balloon pump J Cardiothorac Vasc Anesth 2002 16 5 612-614 10.1053/jcan.2002.126926 12407616
38. Tobias JD Berkenbosch JW Russo P Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant Pediatr Crit Care Med 2003 4 1 49-51 10.1097/00130478-200301000-00009 12656542
39. Naik VN Mazer CD Latter DA Teitel JM Hare GM Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass Can J Anaesth 2003 50 6 599-602 12826554
40. Hendriks HG van der Maaten JM de Wolf J Waterbolk TW Slooff MJ van der Meer J An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII Anesth Analg 2001 93 2 287 9, 2nd contents page 10.1097/ 00000539-200108000-00009 11473845
41. Tanaka KA Waly AA Cooper WA Levy JH Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven) Anesthesiology 2003 98 6 1513-1515 10.1097/ 00000542-200306000-00034 12766668
42. Verrijckt A Proulx F Morneau S Vobecky S Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation J Thorac Cardiovasc Surg 2004 127 6 1812-1813 10.1016/j.jtcvs.2003.12.021 15173742
43. Kastrup M von Heymann C Hotz H Konertz WF Ziemer S Kox WJ Spies C Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta Ann Thorac Surg 2002 74 3 910-912 10.1016/ S0003-4975(02)03700-1 12238862
44. Malherbe S Tsui BC Stobart K Koller J Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII Anesthesiology 2004 100 2 443-445 10.1097/00000542-200402000-00038 14739823
45. Oh JJ Akers WS Lewis D Ramaiah C Flynn JD Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin Pharmacotherapy 2006 26 4 569-577 10.1592/phco.26.4.576 16553518
46. Despotis G Eby, C., Lublin, DM A Review of Transfusion Risks and Optimal Management of Perioperative Bleeding after Cardiac Surgery Transfusion 2006 16934084
47. Zietkiewicz M Garlicki M Domagala J Wierzbicki K Drwila R Pfitzner R Dziatkowiak A Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device J Thorac Cardiovasc Surg 2002 123 2 384-385 10.1067/ mtc.2002.119328 11828314
48. Potapov EV Pasic M Bauer M Hetzer R Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device Ann Thorac Surg 2002 74 6 2182-2183 10.1016/S0003-4975(02)04105-X 12643420
49. McIlroy DR Silvers AJ Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin Anesth Analg 2004 99 1 27-30 10.1213/01.ANE.0000117582.66492.89 15281496
50. Flynn JD Camp PC Jr. Jahania MS Ramaiah C Akers WS Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII Asaio J 2004 50 5 519-521 10.1097/01.MAT.0000136516.16726.35 15497395
51. Flynn JD Pajoumand M Camp PC Jr. Jahania MS Ramaiah C Akers WS Recombinant factor VIIa for refractory bleeding following orthotopic heart transplantation Ann Pharmacother 2004 38 10 1639-1642 10.1345/ aph.1E123 15340124
52. Kogan A Berman M Kassif Y Raanani E Stamler A Ben Gal T Stein M Erez E Vidne BA Sahar G Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation J Heart Lung Transplant 2005 24 3 347-349 10.1016/ j.healun.2003.12.001 15737765
53. Sheth S Dimichele D Lee M Lamour J Quaegebeur J Hsu D Addonizio L Piomelli S Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: Perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa Haemophilia 2001 7 2 227-232 10.1046/j.1365-2516.2001.00483.x 11260285
54. Stratmann G deSilva AM Tseng EE Hambleton J Balea M Romo AJ Mann MJ Achorn NL Moskalik WF Hoopes CW Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia Anesth Analg 2004 98 6 1635-9, table of contents 10.1213/01.ANE.0000114072.71353.D5 15155316
55. Eikelboom JW Bird R Blythe D Coyle L Gan E Harvey M Isbister J Leahy M McIlroy D Rahimpanah F Ramanthan S Strasser S Ward C Watts A Towler S Yi Q Recombinant activated factor VII for the treatment of life-threatening haemorrhage Blood Coagul Fibrinolysis 2003 14 8 713-717 10.1097/ 00001721-200312000-00004 14614349
56. Vanek T Straka Z Hrabak J Jares M Brucek PJ Votava J Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding Jpn Heart J 2004 45 5 855-860 10.1536/ jhj.45.855 15557726
57. Karkouti K Beattie WS Wijeysundera DN Yau TM McCluskey SA Ghannam M Sutton D van Rensburg A Karski J Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis Transfusion 2005 45 1 26-34 10.1111/ j.1537-2995.2005.04216.x 15647015
58. Karkouti K Yau TM Riazi S Dattilo KM Wasowicz M Meineri M McCluskey SA Wijeysundera DN van Rensburg A Beattie WS Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery Can J Anaesth 2006 53 8 802-809 16873347
59. Hyllner M Houltz E Jeppsson A Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery Eur J Cardiothorac Surg 2005 28 2 254-258 10.1016/j.ejcts.2005.04.021 15935687
60. Walsham J Fraser JF Mullany D Ziegenfus M Chinthamuneedi M Dunning J Tesar P The use of recombinant activated factor VII for refractory bleeding post complex cardiothoracic surgery Anaesth Intensive Care 2006 34 1 13-20 16494143
61. Raivio P Suojaranta-Ylinen R Kuitunen AH Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery Ann Thorac Surg 2005 80 1 66-71 10.1016/j.athoracsur.2005.02.044 15975342
62. Al Douri M Shafi T Al Khudairi D Al Bokhari E Black L Akinwale N Osman Musa M Al Homaidhi A Al Fagih M Borum Andreasen R Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery Blood Coagul Fibrinolysis 2000 11 Suppl 1 S121-7 10850577
63. Bishop CV Renwick WE Hogan C Haeusler M Tuckfield A Tatoulis J Recombinant activated factor VII: Treating postoperative hemorrhage in cardiac surgery Ann Thorac Surg 2006 81 3 875-879 10.1016/ j.athoracsur.2005.09.003 16488687
64. Gowers CJ Parr MJ Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy Anaesth Intensive Care 2005 33 2 196-200 15960401
65. Halkos ME Levy JH Chen E Reddy VS Lattouf OM Guyton RA Song HK Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery Ann Thorac Surg 2005 79 4 1303-1306 10.1016/j.athoracsur.2004.09.034 15797067
66. Aggarwal A Malkovska V Catlett JP Alcorn K Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage Thromb J 2004 2 1 9 535534 15530167 10.1186/1477-9560-2-9
67. Clark AD Gordon WC Walker ID Tait RC 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective Vox Sang 2004 86 2 120-124 10.1111/j.0042-9007.2004.00393.x 15023181
68. von Heymann C Redlich U Jain U Kastrup M Schroeder T Sander M Grosse J Ziemer S Koscielny J Konertz WF Wernecke KD Spies C Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy Crit Care Med 2005 33 10 2241-2246 10.1097/01.CCM.0000181527.47749.57 16215377
69. O'Connell NM Perry DJ Hodgson AJ O'Shaughnessy DF Laffan MA Smith OP Recombinant FVIIa in the management of uncontrolled hemorrhage Transfusion 2003 43 12 1711-1716 10.1046/j.0041-1132.2003.00577.x 14641868
70. Romagnoli S Bevilacqua S Gelsomino S Pradella S Ghilli L Rostagno C Gensini GF Sorbara C Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery Anesth Analg 2006 102 5 1320-1326 10.1213/ 01.ane.0000209023.96418.e5 16632803
71. van de Garde EM Bras LJ Heijmen RH Knibbe CA van Dongen EP Wiltink EH Biesma DH Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients J Cardiothorac Vasc Anesth 2006 20 4 573-575 10.1053/j.jvca.2005.06.005 16884993